Genetically Engineered T Cells Expressing a HER2-specific Chimeric Receptor Mediate Antigen-Specific Tumor Regression
Cancer Gene Therapy - United Kingdom
doi 10.1038/cgt.2008.5
Full Text
Open PDFAbstract
Available in full text
Date
February 22, 2008
Authors
Publisher
Springer Science and Business Media LLC